Literature DB >> 35579794

Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children.

Pınar Şimşek-Onat1, Hayriye Hizarcioglu-Gulsen2, Yasin Maruf Ergen2, Ersin Gumus2, Hasan Özen2, Hülya Demir2, Seza Özen3, İnci Nur Saltık-Temizel2.   

Abstract

BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) is a simple and inexpensive inflammation biomarker that reflects systemic inflammation based on complete blood count values. AIMS: In our study, we aimed to compare the NLR values in pediatric inflammatory bowel disease (IBD) and in healthy controls, and to define NLR levels in children with IBD during diagnosis, active disease, and remission.
METHODS: NLR values of patients with IBD at diagnosis, remission, and active disease of the patients were recorded retrospectively. Age- and sex-matched healthy subjects enrolled as the control group.
RESULTS: Sixty-three patients with IBD and 92 healthy subjects as the control group enrolled. The mean age of the patients with IBD was 9.31 ± 5.24 years, and 57.1% were males. The mean NLR values of the patients with IBD at diagnosis and remission were significantly higher than that of healthy controls (p < 0.001). The mean NLR values of the patients at diagnosis and active disease were significantly higher than that of during remission (p < 0.001). The best cutoff of NLR for prediction of diagnosis of IBD in children was 1.46 with a sensitivity of 86.2% and specificity of 93.5%. There was no significant difference regarding NLR between patients with IBD with and without associated diseases. At diagnosis the mean NLR level of patients with Crohn's disease was significantly higher than that of ulcerative colitis (p = 0.019).
CONCLUSIONS: It was shown for the first time that NLR levels were significantly increased at diagnosis and active disease of childhood IBD, compared to the remission period. We believe that NLR can be a non-invasive inflammatory biomarker that should be used in the initial evaluation and follow-up of the disease activity in children.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Crohn’s disease; Inflammation biomarker; NLR; Neutrophil-to-lymphocyte ratio; Ulcerative colitis

Year:  2022        PMID: 35579794     DOI: 10.1007/s10620-022-07547-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  2 in total

1.  Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity.

Authors:  G Acarturk; A Acay; K Demir; M S Ulu; A Ahsen; S Yuksel
Journal:  Bratisl Lek Listy       Date:  2015       Impact factor: 1.278

2.  Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.

Authors:  Sheng-Qiang Gao; Li-Dong Huang; Rui-Jie Dai; Dong-Dong Chen; Wei-Jian Hu; Yun-Feng Shan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  2 in total
  2 in total

1.  C-Reactive Protein/Albumin Ratio at Diagnosis of Pediatric Inflammatory Bowel Disease: A Retrospective Multi-Center Study.

Authors:  Aleksandra Glapa-Nowak; Mariusz Szczepanik; Aleksandra Banaszkiewicz; Jarosław Kwiecień; Anna Szaflarska-Popławska; Urszula Grzybowska-Chlebowczyk; Marcin Osiecki; Jarosław Kierkuś; Marcin Dziekiewicz; Jarosław Walkowiak
Journal:  Med Sci Monit       Date:  2022-09-14

2.  High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen.

Authors:  Richard E Kast
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.